DE3013837A1 - Diagnostische methode - Google Patents

Diagnostische methode

Info

Publication number
DE3013837A1
DE3013837A1 DE19803013837 DE3013837A DE3013837A1 DE 3013837 A1 DE3013837 A1 DE 3013837A1 DE 19803013837 DE19803013837 DE 19803013837 DE 3013837 A DE3013837 A DE 3013837A DE 3013837 A1 DE3013837 A1 DE 3013837A1
Authority
DE
Germany
Prior art keywords
cancer
concentration
dna
inhibitor protein
bleomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803013837
Other languages
German (de)
English (en)
Inventor
Stanley T Crooke
Louis Galvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE3013837A1 publication Critical patent/DE3013837A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G01N33/5755—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G01N33/57585—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
DE19803013837 1979-04-10 1980-04-10 Diagnostische methode Withdrawn DE3013837A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
DE3013837A1 true DE3013837A1 (de) 1980-10-30

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803013837 Withdrawn DE3013837A1 (de) 1979-04-10 1980-04-10 Diagnostische methode

Country Status (24)

Country Link
JP (1) JPS55143441A (OSRAM)
KR (1) KR830002502A (OSRAM)
AR (1) AR222700A1 (OSRAM)
AT (1) AT365343B (OSRAM)
AU (1) AU536522B2 (OSRAM)
BE (1) BE882669A (OSRAM)
CH (1) CH644453A5 (OSRAM)
DE (1) DE3013837A1 (OSRAM)
DK (1) DK149980A (OSRAM)
ES (1) ES8103380A1 (OSRAM)
FI (1) FI801078A7 (OSRAM)
FR (1) FR2454099A1 (OSRAM)
GB (1) GB2047712B (OSRAM)
GR (1) GR67692B (OSRAM)
HU (1) HU183122B (OSRAM)
IE (1) IE49981B1 (OSRAM)
IL (1) IL59772A (OSRAM)
IT (1) IT1143135B (OSRAM)
LU (1) LU82345A1 (OSRAM)
NL (1) NL8002094A (OSRAM)
NO (1) NO801018L (OSRAM)
PH (1) PH15637A (OSRAM)
SE (1) SE8002602L (OSRAM)
ZA (1) ZA802141B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR830002502A (ko) 1983-05-30
FR2454099B1 (OSRAM) 1984-01-27
NO801018L (no) 1980-10-13
IE800693L (en) 1980-10-10
LU82345A1 (fr) 1980-12-16
IE49981B1 (en) 1986-01-22
DK149980A (da) 1980-10-11
JPS55143441A (en) 1980-11-08
IT8048370A0 (it) 1980-04-09
ES490396A0 (es) 1981-02-16
GB2047712B (en) 1983-02-23
GR67692B (OSRAM) 1981-09-07
GB2047712A (en) 1980-12-03
AR222700A1 (es) 1981-06-15
NL8002094A (nl) 1980-10-14
AU5719380A (en) 1980-10-16
ZA802141B (en) 1981-04-29
IT1143135B (it) 1986-10-22
FR2454099A1 (fr) 1980-11-07
AT365343B (de) 1982-01-11
IL59772A (en) 1983-05-15
ES8103380A1 (es) 1981-02-16
IL59772A0 (en) 1980-06-30
AU536522B2 (en) 1984-05-10
HU183122B (en) 1984-04-28
SE8002602L (sv) 1980-12-09
CH644453A5 (fr) 1984-07-31
PH15637A (en) 1983-03-11
ATA195780A (de) 1981-05-15
FI801078A7 (fi) 1981-01-01
BE882669A (fr) 1980-10-06

Similar Documents

Publication Publication Date Title
DE2029499C3 (de) Verfahren zum Nachweis der Anwesenheit von carcinoembryonalen Antigenen im Blut
DE69930666T2 (de) Krebsnachweisverfahren und reagenzien
CH648330A5 (de) Tumor-spezifische glykoproteine und verfahren zu deren herstellung.
EP1409727A2 (de) Verfahren und diagnose-kit zur selektionierung und/oder zum qualitativen und/oder quantitativen nachweis von zellen
CH630465A5 (de) Verfahren zum nachweis oder zur bestimmung eines antikoerper/antigen-komplexes in einer fluidprobe.
EP0021152A1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
DE3003301A1 (de) Verfahren zur bestimmung von mit tumoren vorkommenden glykolbindungen enthaltende substanzen und testmittel zur durchfuehrung des verfahrens
US4188189A (en) Quantitative testing for vitamin B12
DE69108554T2 (de) Analyse der varianten von analyten.
EP1318403B1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE19920704C1 (de) Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
US4270924A (en) Diagnostic method for detecting cancer
EP0037963B1 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2804940A1 (de) Verfahren zur herstellung antigener substanzen und nachweismaterial
DE68907365T2 (de) Verfahren zur Bestimmung des Vorhandenseins leichter Ketten in Urinproben, Komplex von Vorbereitungen zur Erledigung des Verfahrens und damit verbundenes Reagenz.
EP1493034A2 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE3013837A1 (de) Diagnostische methode
WO2003048776A1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 125
CH645726A5 (de) Praeparat zur bestimmung von menschlichem immunoglobulin g, verfahren zu seiner herstellung und seine verwendung.
EP0594873B1 (de) Verfahren zur quantitativen Bestimmung von krankheitsspezifischen Antigenen und Vorrichtung zur Durchführung des Verfahrens
EP1314038B1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
DE3638767A1 (de) Laktoferrin enthaltendes inkubationsmedium fuer festphasenimmunometrisches verfahren und seine verwendung
EP1711831B1 (de) Diagnose von sepsis durch selektive bestimmung der konzentration der cu/zn superoxiddismutase (cu/zn sod) in patientenproben
DE69021631T2 (de) Diagnostische Zusammenstellung zum Nachweis von rheumatischer Arthritis.
DE3546014A1 (de) Verfahren zur bestimmung der bindungskapazitaet des thyroxin bindenden tbg

Legal Events

Date Code Title Description
8141 Disposal/no request for examination